- Market Realist•1 hour ago
Vertex expects to earn revenues in the range of $1.79 billion–$2.01 billion from its cystic fibrosis franchise in 2017.
- Market Realist•3 hours ago
Vertex (VRTX) has projected Orkambi’s revenues to fall in the range of $1.0 billion–$1.3 billion in 2017.
- Market Realist•4 hours ago
For 2017, Vertex has developed a three-pronged growth strategy aimed at securing reimbursements in European markets.
VRTX : Summary for Vertex Pharmaceuticals Incorpor - Yahoo Finance
Vertex Pharmaceuticals Incorporated (VRTX)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||84.50 x 200|
|Ask||89.49 x 100|
|Day's Range||84.67 - 86.11|
|52 Week Range||71.46 - 103.73|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-187.11|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|